ICU vs ACHV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

ICU

45.2
AI Score
VS
ACHV Wins

ACHV

58.2
AI Score

Investment Advisor Scores

ICU

45score
Recommendation
HOLD

ACHV

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ICU ACHV Winner
Net Income -12.15M -16.39M ICU
ROE -116.6% -90.8% ACHV
ROA -85.8% -77.8% ACHV
Total Assets 14.16M 21.08M ACHV
Cash 11.98M 16.66M ACHV
Current Ratio 3.63 6.04 ACHV

Relative Price Performance (Last 90 Days)

ICU 1M: -29.9% · 3M: -32.5% ACHV 1M: -17.1% · 3M: +5.0%

Current Technical Phase

ICU

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.8%), weak momentum, RSI 37

RSI (14): 36.8 · Price: $2.41

ACHV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 36.4 · Price: $6.49

Fundamentals Snapshot

Metric ICU ACHV
Market Cap — —
Forward P/E -1.0 -10.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.8% 0.0%
Gross Margin 0.9% —
Operating Margin -6.2% 0.0%
EPS -2.97 -1.69
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ACHV is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.